Congenital Adrenal Hyperplasia: A Review of 21-Hydroxylase Deficiency and Diagnostic Challenges
March 2009
in “
Dermato-endocrinology
”
New to Hydrocortisone? There is a guide in the encyclopedia. Read the guide → 
Studysummary This review discusses the evaluation, clinical presentation, and cutaneous manifestations of congenital adrenal hyperplasia, focusing on differential diagnosis challenges with polycystic ovary syndrome, and reports no new clinical findings.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The 2009 document reviews Congenital Adrenal Hyperplasia (CAH), particularly focusing on the most common form, 21-hydroxylase deficiency, which accounts for 95% of cases. CAH is characterized by enzyme defects leading to deficiencies in cortisol and/or aldosterone and excess androgens, causing symptoms like acne, androgenetic alopecia, and hirsutism. The review highlights the challenge of differentiating non-classical CAH (NCAH) from conditions like polycystic ovary syndrome (PCOS) and discusses diagnostic methods such as the ACTH stimulation test. It also notes that most men with NCAH are fertile and do not have impaired cortisol synthesis during stress. A study within the document found that 2.2% of women with androgen excess symptoms had NCAH. Diagnosis can be complex due to borderline biochemical data, and treatments vary from managing skin symptoms to reducing ACTH and androgen production. The document emphasizes the importance of a multidisciplinary approach for managing CAH due to its significant dermatological impact.
